ArticleMethodsX2025
Use of cryopreserved whole blood samples in the Comet assay for detection of DNA damage in human population studies.
Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Many human population studies rely on blood samples to test for DNA damage as a biomarker of occupational or environmental exposures, nutrition, disease states or other health concerns. Often sample collection occurs outside of clinical settings in locations lacking immediate access to appropriate technical equipment. We describe a method for the collection of whole blood using dimethyl sulfoxide stabilization followed by cryopreservation that is suitable for samples collected in settings with minimal laboratory equipment. The impact of parameters such as temperature and time of cryopreservation on DNA damage was determined as measured by the comet assay. This method will assist researchers in defining conditions post-phlebotomy to maintain DNA integrity before analysis of DNA damage. We provide evidence that a limited number of freeze thaw cycles are feasible which allows for secondary analysis of samples. Proof of concept is further illustrated through samples collected in remote locations.•Freshly drawn whole blood is aliquoted into DMSO containing cryotubes with slow freeze followed by long term storage in liquid nitrogen which allows repeat sample analysis (1-2 freeze/thaw cycles).•Use of internal quality assurance samples ensures the reliability of DNA damage findings when analysis is conducted at different times over the course of an extended study.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.